Jonathan Silverstein, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 157,200 shares at $286.24 ($45.1M) on 2015-03-26, disclosed to the SEC on 2015-03-30.
Open-market sale of $45.1M ICPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $281.11 | 5,623 | $1.6M | 3.5% |
| 2 | $282.13 | 8,397 | $2.4M | 5.3% |
| 3 | $282.87 | 9,357 | $2.6M | 5.9% |
| 4 | $284.20 | 16,845 | $4.8M | 10.6% |
| 5 | $285.18 | 23,903 | $6.8M | 15.1% |
| 6 | $286.24 | 7,611 |
| $2.2M |
| 4.8% |
| 7 | $287.16 | 18,041 | $5.2M | 11.5% |
| 8 | $288.11 | 26,028 | $7.5M | 16.6% |
| 9 | $289.07 | 15,131 | $4.4M | 9.7% |
| 10 | $290.02 | 13,974 | $4.1M | 9.0% |
| 11 | $291.12 | 3,700 | $1.1M | 2.4% |
| 12 | $292.13 | 6,000 | $1.8M | 3.9% |
| 13 | $293.85 | 2,500 | $735K | 1.6% |
| 14 | $294.82 | 90 | $27K | 0.1% |
| Total | $286.75 avg | 157,200 | $45.1M | 100% |
| Filing → |
| GKOS | SELL | 2018-03-06 | $26.8M | — | Filing → |
| TORC | BUY | 2018-01-30 | $8.0M | — | Filing → |
| GKOS | SELL | 2017-09-05 | $22.5M | — | Filing → |